Genesis Therapeutics: Revolutionizing Drug Discovery with AI
Genesis Therapeutics is an innovative biotech company harnessing the power of AI to advance drug discovery. Using advanced molecular AI technology, the company is unlocking new protein targets and exploring uncharted chemical space to develop life-changing medicines.
🔬 By combining 3D spatial graph modeling and molecular simulation, Genesis Therapeutics generates groundbreaking drug candidates.
👥 With a team of experienced drug hunters, deep learning researchers, and software engineers, the company is committed to applying AI in biochemistry to combat severe disorders.
🚀 Through its sophisticated AI technology, Genesis Therapeutics aims to revolutionize the biotech field.
🎯 Strategic partnerships with industry leaders like Eli Lilly, Roche, and Genentech further validate its groundbreaking approach.
💰 Backed by substantial investments, including a recent $200 million Series B funding round, the company is well-positioned for success.
Genesis Therapeutics is pioneering AI-driven drug discovery, accelerating the development of vital medicines for global patients. 🌍💊
